Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

SAN FRANCISCO, May 13, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference being held at the Nasdaq Headquarters in New York City on May 20, 2025: H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025 – webcast to be available at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time – link hereThe fireside chat will be accessible via the webcast l ...